MDT · News · 20260923N
Revenue Performance and Mix
Medtronic plc · 2026-09-23 · Importance 43 · Surprise 32 · Contradicted
Medtronic delivered approximately 7% organic revenue growth in Q1 FY27. Cardiovascular and Neuroscience were identified as sources of notable strength in the quarter. Cardiac Ablation Solutions has become a meaningful contributor to the company’s growth profile.
Key facts
- Medtronic delivered organic revenue growth of ~7% in Q1 FY27. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +7.0% | Medtronic delivered organic revenue growth of ~7% in Q1 FY27. |